Sort
85,873 grants matching “alzheimers”
Cognitive and Neurobiological Approaches to Plasticity (CNAP) Center Phase 2
$2,250,623David Edward Thompson · Kansas State University · P20 · FY2024 · GM
Microglial function of GWAS risk factor BIN1 in Alzheimer's disease pathogenesis and inflammatory signaling
$2,250,452Gopal Thinakaran · University Of South Florida · RF1 · FY2022 · AG
Alterations In Lipid Metabolism In The Nervous System By Ethanol
$2,250,356Hee-Yong Kim · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Development of a MT-stabilizing agent for the treatment of tauopathies
$2,250,355Conor Caffrey · University Of California, San Diego · U01 · FY2025 · AG
Dementia with Lewy Bodies Consortium
$2,250,274James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · NS
UHC/CWRU ALZHEIMER'S DISEASE RESEARCH CENTER
$2,249,912Case Western Reserve University · P50 · FY2004 · AG
Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.
$2,249,540Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2025 · GM
Colorado Adoption Project/Twin Study of Lifespan behavioral development & cognitive aging [CATSLife2]
$2,248,844Chandra A Reynolds · University Of Colorado · R01 · FY2023 · AG
ADRC of the University of California, Irvine
$2,248,613Frank M Laferla · University Of California-Irvine · P50 · FY2014 · AG
Core B Clinical
$2,247,754Marilyn S Albert · Johns Hopkins University · U19 · FY2023 · AG
Aging and Exercise Effects of Dural Lymphatic Clearance in Healthy Human and Diabetic Brains
$2,247,456Mitsue Miyazaki · University Of California, San Diego · RF1 · FY2022 · AG
Dementia and Value of Home Time
$2,246,697Courtney Harold Van Houtven · Duke University · RF1 · FY2021 · AG
Data Science Research
$2,246,333Mark W Craven · University Of Wisconsin-Madison · U54 · FY2017 · AI
Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP)
$2,246,093Richard Mayeux · Columbia University Health Sciences · R01 · FY2025 · AG
Alzheimer's Disease Core Center
$2,245,824John Q. Trojanowski · University Of Pennsylvania · P30 · FY2018 · AG
Identification of small molecule inhibitors of tau pathology utilizing a novel primary neuronal assay.
$2,245,547Kurt R. Brunden · University Of Pennsylvania · RF1 · FY2020 · AG
The VETSA Longitudinal MRI Twin Study of Aging
$2,245,016William S Kremen · University Of California, San Diego · R01 · FY2017 · AG
Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease
$2,244,795Manu S Goyal · Washington University · RF1 · FY2022 · AG
Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).
$2,244,681Niccolo Terrando · Duke University · RF1 · FY2022 · AG
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
$2,244,471Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2023 · AG
Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience
$2,243,953Sudha Seshadri · University Of Texas Hlth Science Center · R01 · FY2020 · AG
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,243,861Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG
Genetic Architecture of Alzheimerâs disease Proteinopathies
$2,243,331M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG
AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR
$2,243,312University Of Southern California · P01 · FY2004 · AG
Investigations of targets, mechanisms, and optimal delivery of therapeutic ketosis for functional longevity and treatment of Alzheimer's disease
$2,242,722Gino A Cortopassi · University Of California At Davis · P01 · FY2019 · AG